Some Laboratory Corporation of America Holdings (NYSE:LH) shareholders may be a little concerned to see that the CFO & Executive VP, Glenn Eisenberg, recently sold a substantial US$4.4m worth of stock at a price of US$216 per share. That sale reduced their total holding by 46% which is hardly insignificant, but far from the worst we've seen.
Laboratory Corporation of America Holdings Insider Transactions Over The Last Year
In fact, the recent sale by Glenn Eisenberg was the biggest sale of Laboratory Corporation of America Holdings shares made by an insider individual in the last twelve months, according to our records. That means that an insider was selling shares at below the current price (US$219). As a general rule we consider it to be discouraging when insiders are selling below the current price, because it suggests they were happy with a lower valuation. While insider selling is not a positive sign, we can't be sure if it does mean insiders think the shares are fully valued, so it's only a weak sign. We note that the biggest single sale was only 46%of Glenn Eisenberg's holding.
Insiders in Laboratory Corporation of America Holdings didn't buy any shares in the last year. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. By clicking on the graph below, you can see the precise details of each insider transaction!
I will like Laboratory Corporation of America Holdings better if I see some big insider buys. While we wait, check out this free list of growing companies with considerable, recent, insider buying.
Insider Ownership
For a common shareholder, it is worth checking how many shares are held by company insiders. I reckon it's a good sign if insiders own a significant number of shares in the company. Insiders own 0.3% of Laboratory Corporation of America Holdings shares, worth about US$61m. We've certainly seen higher levels of insider ownership elsewhere, but these holdings are enough to suggest alignment between insiders and the other shareholders.
So What Does This Data Suggest About Laboratory Corporation of America Holdings Insiders?
Insiders haven't bought Laboratory Corporation of America Holdings stock in the last three months, but there was some selling. And even if we look at the last year, we didn't see any purchases. Insider ownership isn't particularly high, so this analysis makes us cautious about the company. We'd practice some caution before buying! So while it's helpful to know what insiders are doing in terms of buying or selling, it's also helpful to know the risks that a particular company is facing. While conducting our analysis, we found that Laboratory Corporation of America Holdings has 4 warning signs and it would be unwise to ignore them.
If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.
Have feedback on this article? Concerned about the content?Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Laboratory Corporation of America Holdings (NYSE:LH)の株主の一部は、最近のCFO兼エグゼクティブバイスプレジデントのGlenn Eisenbergによる大量の株式売却(株価216ドルで4.4百万ドル分)を見て、少し心配しているかもしれません。 この売却により、彼らの合計保有分は46%減少しました。 重大なことではないですが、最悪のものからは遠く離れています。
過去12か月におけるLaboratory Corporation of America Holdingsのインサイダートランザクション
実際、Glenn Eisenberg氏による最近の株式売却は、当社の記録によると、過去12か月間に個人インサイダーによって行われたLaboratory Corporation of America Holdingsの株式の中で最大の売り注文です。つまり、インサイダーが現時点の価格(219ドル)以下で株式を売っていたということです。現在の価格よりも低い価格で売っている際には、インサイダーが低い評価額に満足していたことを示すため、信頼性に欠けると考えます。インサイダートランザクションが売出しの場合、株価が適正価格であると考えても、確信が持てないため、弱い兆候にすぎません。Glenn Eisenberg氏の保有分の最大売却が全体の46%だけであったことに留意することができます。
インサイダーが大量の株式を購入するのを見るまで、私はLaboratory Corporation of America Holdingsを好みます。買い増しの激しい成長銘柄の無料リストを表示して待ちながら、同社を確認してください。
インサイダーオーナーシップ
一般的な株主として、企業内部者が保有する株式の数をチェックする価値があります。企業内部者が株式を多数保有している場合、それは良い兆候だと思います。内部者はLaboratory Corporation of America Holdingsの株式の3%(約61百万ドル相当)を保有しています。より高い水準のオーナーシップを見たことはありますが、これらの保有量は、内部者と他の株主の間のアライメントを示唆して十分だと考えます。
これらのデータから、Laboratory Corporation of America Holdingsのインサイダーについて何が示唆されているのでしょうか?
インサイダーは過去3か月間にLaboratory Corporation of America Holdingsの株式を購入していませんが、売却がありました。過去1年間についても、購入の記録を見ることはできませんでした。インサイダーオーナーシップが特に高くないため、同社については慎重に分析することが必要です。購入前にはいくらか注意を払う必要があります!インサイダーが買い付けているか売り出しているかについて知ることは、役割ですが、特定の会社が抱えているリスクを知ることは同様に役立ちます。当社の分析中、Laboratory Corporation of America Holdingsには4つの警告サインがあることが分かりました。それらを無視することは賢明ではありません。